Browsing: non-small-cell lung cancer

Lung cancer_immunotherapy_immunooncology
0

Roche has announced results from its Phase III IMpower130 trial. The findings demonstrate that Tecentriq® plus chemotherapy helped individuals with metastatic non-squamous NSCLC, who lived significantly longer compared with those who received chemotherapy alone

1 2 3 10